• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

青少年和青年(AYA)肿瘤学:首个A。

Adolescent and young adult (AYA) oncology: the first A.

作者信息

Bleyer Archie

机构信息

St. Charles Medical Center, 2500 NE Neff Rd., Bend, OR 97701, USA.

出版信息

Pediatr Hematol Oncol. 2007 Jul-Aug;24(5):325-36. doi: 10.1080/08880010701316850.

DOI:10.1080/08880010701316850
PMID:17613877
Abstract

Whereas adolescents with cancer as a group used to have a better prognosis than children with malignant disease, trends suggest that the overall survival of 15- to 19-year-olds is now worse than in younger patients. Also, the incidence of cancer is higher in 15- to 19-year age span than during the first 15 years of life. In 2006, the U.S. National Cancer Institute (NCI) and the Lance Armstrong Foundation conducted a Program Review Group (PRG) of the Adolescent and young Adult (AYA) problem. Recommendations covered awareness, prevention/cancer control/epidemiology/risk, biology, access, health insurance, clinical care models, clinical trials/research, special populations, psychosocial/behavioral factors, health-related quality of life, and long-term effects. This Commentary reviews each of the primary executive recommendations of the PRG report with respect to their adolescent oncology perspective and application. Primary implementation of the recommendations is responsibility of a new consortium of organizations devoted to assisting adolescents and young adults with cancer, the LiveStrong Young Adult Alliance, a program of the Lance Armstrong Foundation. Prior programs included the Children's Oncology Group AYA Committee and two disease-specific initiatives: the Intergroup Consortium Against Sarcoma and a clinical trial in young adults with acute lymphoblastic leukemia that will be conducted by Cancer and Leukemia Group B, the Southwest Oncology Group, and Eastern Cooperative Oncology Group. Preliminary evidence indicates that these efforts have already had measurable success.

摘要

以往,患癌青少年群体的预后通常优于患恶性疾病的儿童,但目前的趋势表明,15至19岁青少年的总体生存率现在低于年龄更小的患者。此外,15至19岁年龄段的癌症发病率高于生命的前15年。2006年,美国国家癌症研究所(NCI)和兰斯·阿姆斯特朗基金会针对青少年和青年成人(AYA)问题开展了一次项目审查小组(PRG)会议。建议涵盖了认知、预防/癌症控制/流行病学/风险、生物学、可及性、健康保险、临床护理模式、临床试验/研究、特殊人群、心理社会/行为因素、健康相关生活质量以及长期影响等方面。本述评从青少年肿瘤学的角度及应用方面,对PRG报告的每一项主要执行建议进行了审视。这些建议的主要实施工作由一个致力于帮助患癌青少年和青年成人的新组织联盟负责,即“坚强活下去青年成人联盟”,它是兰斯·阿姆斯特朗基金会的一个项目。之前的项目包括儿童肿瘤学组AYA委员会以及两项针对特定疾病的倡议:肉瘤国际协作组,以及一项针对急性淋巴细胞白血病青年成人患者的临床试验,该试验将由癌症与白血病B组、西南肿瘤学组以及东部肿瘤协作组共同开展。初步证据表明,这些努力已经取得了显著成效。

相似文献

1
Adolescent and young adult (AYA) oncology: the first A.青少年和青年(AYA)肿瘤学:首个A。
Pediatr Hematol Oncol. 2007 Jul-Aug;24(5):325-36. doi: 10.1080/08880010701316850.
2
Adolescent and young adult oncology training for health professionals: a position statement.青少年和青年肿瘤学培训对卫生专业人员:立场声明。
J Clin Oncol. 2010 Nov 10;28(32):4858-61. doi: 10.1200/JCO.2010.30.5508. Epub 2010 Sep 7.
3
Active therapy and models of care for adolescents and young adults with cancer.癌症青少年和年轻成人的积极治疗和护理模式。
Cancer. 2011 May 15;117(10 Suppl):2316-22. doi: 10.1002/cncr.26048.
4
Challenges in the recruitment of adolescents and young adults to cancer clinical trials.招募青少年和青年参与癌症临床试验面临的挑战。
Cancer. 2007 Dec 1;110(11):2385-93. doi: 10.1002/cncr.23060.
5
Development of risk-based guidelines for pediatric cancer survivors: the Children's Oncology Group Long-Term Follow-Up Guidelines from the Children's Oncology Group Late Effects Committee and Nursing Discipline.基于风险的儿童癌症幸存者指南的制定:来自儿童肿瘤学组迟发效应委员会和护理学科的儿童肿瘤学组长期随访指南
J Clin Oncol. 2004 Dec 15;22(24):4979-90. doi: 10.1200/JCO.2004.11.032. Epub 2004 Dec 2.
6
The History and Accomplishments of the LIVESTRONG Young Adult Alliance.“坚强生活”青年联盟的历史与成就
J Adolesc Young Adult Oncol. 2011 Mar;1(1):43-7. doi: 10.1089/jayao.2010.0006.
7
A comparison of clinical trial enrollment between adolescent and young adult (AYA) oncology patients treated at affiliated adult and pediatric oncology centers.附属成人与儿科肿瘤中心治疗的青少年和青年成人(AYA)肿瘤患者临床试验入组情况的比较。
J Pediatr Hematol Oncol. 2009 Dec;31(12):927-9. doi: 10.1097/MPH.0b013e3181b91180.
8
National cancer clinical trials: children have equal access; adolescents do not.国家癌症临床试验:儿童有平等的参与机会;青少年则没有。
J Adolesc Health. 1997 Dec;21(6):366-73. doi: 10.1016/S1054-139X(97)00110-9.
9
Adolescents and young adults with cancer: the scope of the problem and criticality of clinical trials.患癌青少年及青年:问题的范围及临床试验的关键性
Cancer. 2006 Oct 1;107(7 Suppl):1645-55. doi: 10.1002/cncr.22102.
10
Improved clinical trial enrollment in adolescent and young adult (AYA) oncology patients after the establishment of an AYA oncology program uniting pediatric and medical oncology divisions.在建立了一个将儿科肿瘤学和肿瘤医学部门联合起来的青少年和年轻成人(AYA)肿瘤学项目后,改善了 AYA 肿瘤学患者的临床试验入组。
Cancer. 2012 Jul 15;118(14):3614-7. doi: 10.1002/cncr.26634. Epub 2011 Dec 27.

引用本文的文献

1
Exploring the interconnectedness between health-related quality of life factors among long-term adolescent and young adult cancer survivors (AYAs): a network analysis.探讨长期青少年和年轻成年癌症幸存者(AYAs)中与健康相关的生活质量因素之间的相互关系:网络分析。
Support Care Cancer. 2024 Jan 13;32(2):104. doi: 10.1007/s00520-023-08295-0.
2
The Prolonged Diagnostic Pathway of Young Adults (Aged 25-39) with Cancer in the United Kingdom: Results from the Young Adult Cancer Patient Journey Study.英国25至39岁癌症青年患者的漫长诊断路径:青年癌症患者就医过程研究结果
J Clin Med. 2021 Oct 11;10(20):4646. doi: 10.3390/jcm10204646.
3
Racial Disparities in Children, Adolescents, and Young Adults with Hodgkin Lymphoma Enrolled in the New York State Medicaid Program.
纽约州医疗补助计划中登记的儿童、青少年和青年霍奇金淋巴瘤患者的种族差异。
J Adolesc Young Adult Oncol. 2022 Aug;11(4):360-369. doi: 10.1089/jayao.2021.0131. Epub 2021 Oct 8.
4
Patterns of National Cancer Institute-Sponsored Clinical Trial Enrollment in Black Adolescents and Young Adults.国家癌症研究所资助的临床试验中黑人青少年和年轻成年人的入组模式。
Cancer Med. 2021 Nov;10(21):7620-7628. doi: 10.1002/cam4.4292. Epub 2021 Sep 30.
5
Systematic review of barriers and facilitators to clinical trial enrollment among adolescents and young adults with cancer: Identifying opportunities for intervention.系统评价青少年和青年癌症患者参与临床试验的障碍和促进因素:确定干预机会。
Cancer. 2020 Mar 1;126(5):949-957. doi: 10.1002/cncr.32675. Epub 2019 Dec 23.
6
Survival after cancer in children, adolescents and young adults in the Nordic countries from 1980 to 2013.北欧国家儿童、青少年和青年成年人癌症患者 1980 年至 2013 年的存活率。
Br J Cancer. 2019 Dec;121(12):1079-1084. doi: 10.1038/s41416-019-0632-1. Epub 2019 Nov 13.
7
Delay in Treatment After Cancer Diagnosis in Adolescents and Young Adults: Does Facility Transfer Matter?青少年和青年癌症诊断后的治疗延迟:医疗机构转移是否重要?
J Adolesc Young Adult Oncol. 2019 Jun;8(3):243-253. doi: 10.1089/jayao.2018.0128. Epub 2019 Feb 20.
8
Current considerations in AYA Hodgkin lymphoma.青少年及年轻成人霍奇金淋巴瘤的当前考量。
Br J Haematol. 2019 Jan;184(1):72-81. doi: 10.1111/bjh.15640. Epub 2018 Nov 20.
9
Health professional perceptions of communicating with adolescents and young adults about bone cancer clinical trial participation.卫生专业人员对与青少年和青年就骨癌临床试验参与进行沟通的看法。
Support Care Cancer. 2019 Feb;27(2):467-475. doi: 10.1007/s00520-018-4337-4. Epub 2018 Jul 5.
10
Adolescent and Young Adult Testicular Germ Cell Tumors: Special Considerations.青少年及青年睾丸生殖细胞肿瘤:特殊考量
Adv Urol. 2018 Jan 31;2018:2375176. doi: 10.1155/2018/2375176. eCollection 2018.